Literature DB >> 15837991

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

Jean-Jacques Patard1, Emmanuelle Leray, Nathalie Rioux-Leclercq, Luca Cindolo, Vincenzo Ficarra, Amnon Zisman, Alexandre De La Taille, Jacques Tostain, Walter Artibani, Claude C Abbou, Bernard Lobel, François Guillé, Dominique K Chopin, Peter F A Mulders, Christopher G Wood, David A Swanson, Robert A Figlin, Arie S Belldegrun, Allan J Pantuck.   

Abstract

PURPOSE: To analyze to what extent histologic subtype is of prognostic importance in renal cell carcinoma based on a large, international, multicenter experience. PATIENTS AND METHODS: Four thousand sixty-three patients from eight international centers were included in this retrospective study. Histologic subtype (1997 International Union Against Cancer [UICC] criteria of tumor response), age, sex, TNM stage, Fuhrman grade, tumor size, Eastern Cooperative Oncology Goup performance status (ECOG PS), and overall survival were determined in all cases. The prognostic values of clear cell, papillary, and chromophobe histologic features were assessed by uni- and multivariate analysis using the Kaplan-Meier method and Cox model, respectively.
RESULTS: Clear cell, papillary, and chromophobe carcinomas accounted for 3,564 (87.7%), 396 (9.7%) and 103 (2.5%) cases, respectively. In univariate analysis, a trend toward a better survival was observed when clear cell, papillary, and chromophobe histologies were considered prognostic categories (log-rank P = .0007). However, in multivariate analysis, TNM stage, Fuhrman grade and ECOG PS, but not histology, were retained as independent prognostic variables (P < .001).
CONCLUSION: The stratification in three main renal cell carcinoma histologic subtypes as defined by the 1997 UICC-American Joint Committee on Cancer consensus should not be considered a major prognostic variable comparable to TNM stage, Fuhrman grade and ECOG PS.

Entities:  

Mesh:

Year:  2005        PMID: 15837991     DOI: 10.1200/JCO.2005.07.055

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  208 in total

Review 1.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

Review 2.  Chinese guidelines on the management of renal cell carcinoma (2015 edition).

Authors:  Jun Guo; Jianhui Ma; Yan Sun; Shukui Qin; Dingwei Ye; Fangjian Zhou; Zhisong He; Xinan Sheng; Feng Bi; Dengfeng Cao; Yingxia Chen; Yiran Huang; Houjie Liang; Jun Liang; Jiwei Liu; Wenchao Liu; Yueyin Pan; Yongqian Shu; Xin Song; Weibo Wang; Xiuwen Wang; Xiaoan Wu; Xiaodong Xie; Xin Yao; Shiying Yu; Yanqiao Zhang; Aiping Zhou
Journal:  Ann Transl Med       Date:  2015-11

3.  Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).

Authors:  François-Xavier Nouhaud; Jean-Christophe Bernhard; Pierre Bigot; Zine-Eddine Khene; François Audenet; Herve Lang; Sebastien Bergerat; Guillaume Fraisse; Nicolas Grenier; François Cornelis; Cosmina Nedelcu; Sofiane Béjar; Gaëlle Fromont-Hankard; Yves Allory; Véronique Lindner; Virginie Verkarre; Laurent Daniel; Mokrane Yacoub; Jean-Michel Correas; Arnaud Méjean; Nathalie Rioux-Leclercq; Karim Bensalah
Journal:  World J Urol       Date:  2018-05-05       Impact factor: 4.226

4.  [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].

Authors:  E Herrmann; C Wülfing; A Hartmann
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

5.  Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.

Authors:  Serge Ginzburg; Robert Uzzo; Tahseen Al-Saleem; Essel Dulaimi; John Walton; Anthony Corcoran; Elizabeth Plimack; Reza Mehrazin; Jeffrey Tomaszewski; Rosalia Viterbo; David Y T Chen; Richard Greenberg; Marc Smaldone; Alexander Kutikov
Journal:  J Urol       Date:  2013-07-27       Impact factor: 7.450

6.  Pathological characteristics and radiographic correlates of complex renal cysts.

Authors:  Adam C Reese; Pamela T Johnson; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf; Elliot K Fishman; George J Netto; Christian P Pavlovich
Journal:  Urol Oncol       Date:  2014-07-09       Impact factor: 3.498

Review 7.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

8.  MicroRNA-183 promotes the proliferation and metastasis of renal cell carcinoma through targeting Dickkopf-related protein 3.

Authors:  Xiao-Long Zhang; Gang Xu; Yi Zhou; Jia-Jun Yan
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

9.  [Gender-specific characteristics and survival of renal cell carcinoma].

Authors:  A J Schrader; S Sevinc; P J Olbert; A Hegele; Z Varga; R Hofmann
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

10.  Sub-typing of renal cell tumours; contribution of ancillary techniques.

Authors:  Dinesh Pradhan; Nandita Kakkar; Amanjit Bal; Shrawan Kumar Singh; Kusum Joshi
Journal:  Diagn Pathol       Date:  2009-06-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.